Venlo, The Netherlands, August 21, 2020 – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced today a transition in the leadership of its Supervisory Board after an extraordinary meeting of the Supervisory Board and Managing Board. Lawrence A. Rosen, a member of the QIAGEN Supervisory Board since 2013, was appointed by the Supervisory Board as the... Read more
Welsh Government and Life Sciences Hub Wales are supporting plans to build a 200 strong team of specialists at Wales’ soon to be launched Lighthouse Lab, which is set to create additional capacity for the UK’s Covid-19 testing strategy. Work to establish the UK Government’s Lighthouse Lab at Imperial Park in Newport is underpinned by... Read more
IRVINE, Calif., (Aug. 19, 2020) — Zymo Research announced that it was recently granted the CE IVD Mark for its Quick SARS-CoV-2 rRT-PCR Kit. To obtain this certification the product had to comply with the Directive 98/79/EC of the European Parliament and of the Council of 27 October 1998 on in vitro diagnostic medical devices. The Quick SARS-CoV-2 rRT-PCR Kit is... Read more
AUGUST 19, 2020 Research-use-only RNA-ISH probes now available for COVID-19 on our automated platform MINNEAPOLIS, Aug. 19, 2020 /PRNewswire/ — Bio-Techne Corporation (NASDAQ:TECH), in partnership with Leica Biosystems, today announced the automation of RNAscope™ COVID-19 probes on BOND RX*, Leica’s staining platform, for research use only. Researchers now have the ability to automate their COVID-19 research protocols,... Read more
WALTHAM, Mass.–(BUSINESS WIRE)–Aug. 19, 2020– PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the Company will present at Baird’s 2020 Virtual Global Healthcare Conference on Thursday, September 10, 2020 at 8:30 a.m. ET. Jamey Mock, senior vice president and chief financial officer for PerkinElmer, will provide... Read more
Thermo Fisher Scientific Introduces Hematology-Oncology Portfolio for Ion Torrent Genexus System* CARLSBAD, Calif., Aug. 19, 2020 /PRNewswire/ — In hematology oncology, it is critically important to understand the genetics driving acute malignancies to quickly determine how best to address the disease. Today, Thermo Fisher Scientific announces a new portfolio of hematology-oncology assays for the Ion... Read more
REGN-COV2 is Regeneron’s two-antibody combination currently in late-stage clinical trials for the treatment and prevention of COVID-19 infection. The companies will collaborate on developing and manufacturing REGN-COV2. Regeneron will distribute REGN-COV2 in the U.S. and Roche will be responsible for distribution outside the U.S. Under this collaboration, the overall capacity of REGN-COV2 is expected to... Read more
Hilden, Germany, and Germantown, Maryland, August 18, 2020 – QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) launched the innovative QIAseq SARS-CoV-2 Primer Panel for next-generation sequencing (NGS) of the novel coronavirus genome, along with integrated analysis and interpretation workflows for insights into the evolution and spread of the virus that causes COVID-19 disease. The new... Read more
New program helps break down information barriers to cryo-EM adoption to speed development of more effective drugs Read more
(ANN ARBOR, MICH. August 17, 2020) Swift Biosciences, Inc., a leader in the commercialization of DNA and RNA Library Preparation Kits recently launched a new ACE2 Swift Normalase® Amplicon Panel (SNAP) to further research on the main functional receptor for viral entry of Coronavirus. With global numbers of COVID-19 cases increasing, Swift remains committed to providing... Read more